Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlos Zamora Atenza"'
Autor:
Leticia Alserawan, Geòrgia Anguera, Carlos Zamora Atenza, Jorgina Serra López, Laura Martínez-Martínez, Mariona Riudavets Melià, Ivana Sullivan, Andrés Barba Joaquin, Margarita Majem Tarruella, Silvia Vidal
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 20, p 12641 (2022)
Immune-related adverse events (irAEs) are unpredictable autoimmune-like toxicities induced by immune checkpoint inhibitors (ICI). irAEs are a consequence of a breakdown in self-tolerance. ICIs can induce autoantibody formation, and the presence of an
Externí odkaz:
https://doaj.org/article/61f89e0f499e4fbb936319d8bef849fc
Autor:
Rubén Osuna‐Gómez, Silvia Barril, Maria Mulet, Carlos Zamora Atenza, Paloma Millan‐Billi, Ana Pardessus, Douglas E. Brough, Helen Sabzevari, Roshanak T. Semnani, Diego Castillo, Silvia Vidal
Publikováno v:
Immunology. 168:610-621
Pulmonary fibrosis involves various types of immune cells and soluble mediators, including TGF-β and IL-35, a recently identified heterodimeric cytokine that belongs to the IL-12 cytokine family. However, the effect of regulatory IL-35 may play an i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802230165148433efdeacd40c5db8389
https://doi.org/10.1111/imm.13596
https://doi.org/10.1111/imm.13596
Autor:
Carlos Zamora Atenza, Geòrgia Anguera, Mariona Riudavets Melià, Letícia Alserawan De Lamo, Ivana Sullivan, Andrés Barba Joaquin, Jorgina Serra Lopez, M. Angels Ortiz, Maria Mulet, Sílvia Vidal, Margarita Majem
Publikováno v:
Cancer Immunology, Immunotherapy. 71:1823-1835
Tumor PD-L1 expression is a predictive biomarker for patients with NSCLC receiving PD-(L)1 blockade agents. However, although increased tumor PD-L1 expression predicts responsiveness, clinical benefit has been observed regardless of tumor PD-L1 expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a857da021b752dc31cb8a2ed8b18c538
https://doi.org/10.1007/s00262-021-03107-y
https://doi.org/10.1007/s00262-021-03107-y
Autor:
Elisabet Cantó, Esther Garcia Planella, Carlos Zamora-Atenza, Juan Camilo Nieto, Jordi Gordillo, Ma Angels Ortiz, Isidoro Metón, Elena Serrano, Esteban Vegas, Orlando García-Bosch, Cándido Juárez, Sílvia Vidal
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e93910 (2014)
The exact function of interleukin-19 (IL-19) on immune response is poorly understood. In mice, IL-19 up-regulates TNFα and IL-6 expression and its deficiency increases susceptibility to DSS-induced colitis. In humans, IL-19 favors a Th2 response and
Externí odkaz:
https://doaj.org/article/385015253f4f4b73a045699f04ad175c
Autor:
Lluís Puig, María Teresa Sanz-Martínez, Miguel Angel Sánchez Martínez, Esther Moga, Silvia M. Vidal, Carlos Zamora Atenza, Cándido Juárez
Publikováno v:
The Journal of investigative dermatology. 140(6)
Psoriasis is currently considered to be an immune-mediated disease whose patho-mechanisms involve platelet activation, which seems to correlate with the activity of the disease. Platelet activation is associated with the formation of platelet-lymphoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4215ca4657ca9c54e1c0ab1e73dee4aa
https://pubmed.ncbi.nlm.nih.gov/31778714
https://pubmed.ncbi.nlm.nih.gov/31778714
Autor:
Cándido Juárez, Carlos Zamora-Atenza, Josep Maria Llobet, Patricia Moya, Ivan Castellví, M. Angels Ortiz, Cesar Diaz-Lopez, Carme Geli, Cesar Diaz-Torne, Elisabet Cantó, Silvia Vidal, Juan C. Nieto, Jordi Casademont
Publikováno v:
Arthritis Research & Therapy
Introduction Adalimumab is a fully human anti–tumor necrosis factor α (anti-TNFα) monoclonal antibody that specifically blocks the interaction of TNFα with its receptors. It binds both soluble and transmembrane TNFα. We hypothesized that blocki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc41131d010cc6de1c6414837bfb637
https://pubmed.ncbi.nlm.nih.gov/25037855
https://pubmed.ncbi.nlm.nih.gov/25037855